Clairvoyant

Psyence Biomedical Ltd. (NASDAQ:PBM), a biotechnology company focused on creating natural psychedelic-based solutions to address mental health challenges, has issued an update to shareholders, highlighting significant recent developments and upcoming milestones. The company has initiated a Phase...

Psychedelics VC fund Iter Investments has recently closed its last round of Fund I with over $20 million committed, a successful outcome considering the targeted raise in their first fund launch in April 2021, and an indication of investor interest in the psychedelics market. Iter’s team...